Laurus Labs Limited

05/01/2026

Laurus Labs will be attending JPM Health Conference Week 2026, taking place in San Francisco from Jan 12–15, to engage with global healthcare leaders, partners, and innovators shaping the future of the industry.

31/12/2025

Grateful for our people, partners, and communities who make our journey meaningful. Wishing everyone a happy, healthy, and successful New Year.

30/12/2025

We are proud to share that our Visakhapatnam facility has been awarded the Gold Award | Pharma Sector (Large Business) at the India Manufacturing Excellence Awards 2025 by Frost & Sullivan, recognising sustained excellence in manufacturing and operational rigor.

24/12/2025

17/12/2025

As concludes, we reflect on an inspiring week of dialogue and collaboration in Accra, Ghana. At Laurus Labs, we remain committed to advancing affordable, high-quality treatments and strengthening global health systems.

10/12/2025

participated in the Telangana Rising Global Summit 2025. Our CEO, Dr. Satyanarayana Chava, spoke on driving innovation, sustainable chemistry, and how Laurus is preparing for the future of pharma. The session, “Genome Valley & Beyond: Accelerating Innovation in Life Sciences,” was chaired by Sri D. Sridhar Babu and moderated by Dr. Srinivas Oruganti.

05/12/2025

As Laurus Labs marks 20 years of innovation, our TOI feature highlights the next leap in our journey. Dr. Chava emphasized our strategic focus on strengthening CDMO capabilities, supported by calibrated investments in new modalities. He reiterated that CDMO will grow faster than the generics business and will position Laurus strongly for the future.

Read more:
https://www.lauruslabs.com/pdf/PressReleases/Laurus_Labs-The_Times_of_India-Hyderabad-PG06.jpg

01/12/2025

Laurus Labs participated in a key panel at CPHI Noida on Orphan Drug Manufacturing in India – Opportunities, Challenges & the Road Ahead. Our representative Mr. Bharadwaj Mangu, Senior Business Development Manager – FDF Domestic shared industry perspectives on Success Stories & Lessons Learned in Orphan Drug Development. The discussion brought together gov’t, industry & academia to strengthen India’s orphan drug ecosystem and offered deep insights into the rare disease segment.

27/11/2025

successfully concluded its participation at the 25. We had engaging discussions, valuable interactions, and great insights with partners and visitors at Stall No. 36. Thank you for making this event meaningful for us.

18/11/2025

Laurus Labs will be present at the BOS Manchester Conference happening from November 25–26 in Manchester. Drop by Stall No. 36 to learn more about our offerings.

14/11/2025

Join us at the 2025 American Pharma Manufacturing & Outsourcing Summit hosted by at the Westin Boston Seaport District, MA, from November 17–18! Connect with our team on-site and stop by Booth #49 to learn more about Laurus Labs.

12/11/2025

Laurus Labs continues to strengthen its sustainability performance with an impressive improvement in the S&P Global Corporate Sustainability Assessment (CSA) and ESG Scores for 2025. Our overall score now stands at 81, up from 71 last year, reflecting strong progress across Governance (81), Environment (66), and Social (86) dimensions.